Connor, Clark & Lunn Investment Management Ltd. Ideaya Biosciences, Inc. Transaction History
Connor, Clark & Lunn Investment Management Ltd.
- $18.8 Billion
- Q3 2024
A detailed history of Connor, Clark & Lunn Investment Management Ltd. transactions in Ideaya Biosciences, Inc. stock. As of the latest transaction made, Connor, Clark & Lunn Investment Management Ltd. holds 50,370 shares of IDYA stock, worth $1.33 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
50,370
Previous 81,317
38.06%
Holding current value
$1.33 Million
Previous $2.86 Million
44.13%
% of portfolio
0.01%
Previous 0.01%
Shares
4 transactions
Others Institutions Holding IDYA
# of Institutions
216Shares Held
80.8MCall Options Held
69KPut Options Held
20K-
Black Rock Inc. New York, NY6.81MShares$179 Million0.01% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA5.21MShares$137 Million0.38% of portfolio
-
Janus Henderson Group PLC London, X05.16MShares$136 Million0.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.8MShares$126 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.02MShares$106 Million0.01% of portfolio
About IDEAYA Biosciences, Inc.
- Ticker IDYA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,067,700
- Market Cap $1.27B
- Description
- IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company's lead product candidates include IDE397, a methionine adenosyltransferase 2a inhibitor that is in Phase I clinica...